Pharmaco-Invasive Strategy Provides Alternative for Older STEMI Patients Unable to Undergo Primary PCI, STREAM-2 Follow-Up Study Suggests

Need an Account?

Content is available to registered users only. Registration is free.

Register now, or if you’ve already registered, log in.
News

Pharmaco-Invasive Strategy Provides Alternative for Older STEMI Patients Unable to Undergo Primary PCI, STREAM-2 Follow-Up Study Suggests

Posted: 11/13/2023
Author:
Bailey Salimes, CRTonline.org
AHA Coronary 2023 Cardiovascular Pharmacology Late-Breaking Trials STEMI Acute Coronary Syndrome Percutaneous Coronary Intervention News Articles Coronary Interventions

A half-dose of tenecteplase shows similar outcomes to primary percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients who are 60 years of age or older, a new analysis shows.

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Need an Account?

News

Pharmaco-Invasive Strategy Provides Alternative for Older STEMI Patients Unable to Undergo Primary PCI, STREAM-2 Follow-Up Study Suggests

Most Viewed Pages

Explore the Site

Stay Connected